Abstract
Cutaneous manifestations of end-stage renal disease, particularly altered skin pigmentation, are well documented in the literature. Most patients with chronic kidney disease are affected by at least one dermatological condition, which impacts patient morbidity and quality of life. In this chapter we review a diverse group of cutaneous entities seen in patients with chronic renal disease and discuss those that may present with various dyschromias. Recognition of pigmentary alterations and their relationship to skin conditions in the setting of kidney disease is imperative for early diagnosis and management of the underlying process causing the pigmentary alteration. Pigmentary alterations due to primary processes as well as manifestations of secondary processes are presented. The pathogenesis, salient clinical features, and skin-directed treatment of each condition are reviewed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Stedman TL. Stedman’s medical dictionary for the health professions and nursing. Illustrated 5th ed. Baltimore, MD: Wolters Kluwer; 2005. p. 442.
Bolognia JB, Jorizzo JL, Schaffer JV, et al. Dermatology. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012.
Picó MR, Lugo-Somolinos A, Sánchez JL, Burgos-Calderón R. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol. 1992;31(12):860–3.
Smith AG, Shuster S, Comaish JS, Plummer NA, Thody AJ, Alvarez-ude F. Plasma immunoreactive β-melanocyte stimulating hormone and skin pigmentation in chronic renal failure. Br Med J. 1975;1:658–9.
Cordova KB, Oberg TJ, Malik M, Robinson-Bostom L. Dermatologic conditions seen in end-stage renal disease. Semin Dial. 2009;22:45–55.
Shanmugam VK, Steen VD. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol. 2012;24(6):669–76.
Morias P, Santos AL, Baudrier T, Mota AV, Oliveira JP, Azevedo F. Angiokeratomas of Fabry successfully treated with intense pulsed light. J Cosmet Laser Ther. 2008;10:218.
Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol. 2009;53:1621–8.
Almouhawis HA, Leao JC, Fedele S, Porter SR. Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment. J Oral Pathol Med. 2013;42(7):507–16.
Keithi-Reddy SR, Patel TV, Armstrong AW, Singh AK. Uremic pruritus. Kidney Int. 2007;72(3):373–7.
Robinson-Bostom L, DiGiovanna JJ. Cutaneous manifestations of end stage renal disease. J Am Acad Dermatol. 2000;43:975–89.
Goldsmith DJA, Black MM. Skin disorders in the setting of renal failure: invited editorial. J Eur Acad Dermatol Venereol. 2001;15:392–8.
Rivard J, Lim HW. Ultraviolet phototherapy for pruritus. Dermatol Ther. 2005;18(4):344–54.
Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56:569–79.
Glynne P, Deacon A, Goldsmith D, Pusey C, Clutterbuck E. Bullous dermatoses in end-stage renal failure: Porphyria or pseudoporphyria? Am J Kidney Dis. 1999;34:155–60.
Gutzmer R, Wollenberg A, Ugurel S, Homey B, Ganser A, Kapp A. Cutaneous side effects of new antitumor drugs: clinical features and management. BioDrugs. 2009;23(6):377–89.
Mendiratta V, Jain A. Nail dyschromias. Indian J Dermatol Venereol Leprol. 2011;77(6):652–8. doi:10.4103/0378-6323.86473.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Munhutu, M.N., Halder, R.M. (2015). Dyschromias in Renal Disease. In: Nunley, J., Lerma, E. (eds) Dermatological Manifestations of Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2395-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2395-3_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2394-6
Online ISBN: 978-1-4939-2395-3
eBook Packages: MedicineMedicine (R0)